Gsa Capital Partners LLP Sangamo Therapeutics, Inc Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 3,662,478 shares of SGMO stock, worth $1.61 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,662,478
Previous 2,245,449
63.11%
Holding current value
$1.61 Million
Previous $1.22 Million
102.96%
% of portfolio
0.21%
Previous 0.09%
Shares
26 transactions
Others Institutions Holding SGMO
# of Institutions
124Shares Held
62.5MCall Options Held
953KPut Options Held
1.11M-
Vanguard Group Inc Valley Forge, PA11.6MShares$5.11 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.2MShares$4.48 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.07 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.29MShares$1.45 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY2.48MShares$1.09 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $68.9M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...